Status:
ACTIVE_NOT_RECRUITING
NGS-based Germline and Somatic Genetic Test in Ovarian Carcinoma
Lead Sponsor:
European Institute of Oncology
Conditions:
Ovarian Carcinoma
Fallopian Tube Carcinoma
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
For patients with ovarian cancer and biologically related diseases, the implementation of genetic testing in the decision-making process could have an impact both on the risk management for the patien...
Eligibility Criteria
Inclusion
- age 18 or higher
- has signed informed consent
- histologically confirmed ovarian cancer, Fallopian tube cancer, or primary peritoneal cancer.
- Any stage is admitted
- Any histology is admitted
- availability of surgical/bioptic material. Formalin-fixed, paraffinembedded or frozen specimens are both allowed, with no time limitation
Exclusion
- 1\. unable or unwilling to receive genetic counseling
Key Trial Info
Start Date :
June 12 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2025
Estimated Enrollment :
323 Patients enrolled
Trial Details
Trial ID
NCT06972693
Start Date
June 12 2018
End Date
December 30 2025
Last Update
May 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istituto Europeo di Oncologia
Milan, Italy, Italy, 20141